These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex. Fallah A; Weil AG; Wang S; Lewis E; Baca CB; Mathern GW Epilepsy Behav; 2016 Oct; 63():79-88. PubMed ID: 27591681 [TBL] [Abstract][Full Text] [Related]
5. The feast and famine: Epilepsy treatment and treatment gaps in early 21st century. Löscher W; Klein P Neuropharmacology; 2020 Jun; 170():108055. PubMed ID: 32199986 [No Abstract] [Full Text] [Related]
7. Aggravation of seizures and status epilepticus after vagal nerve stimulation therapy: the first pediatric case and review of the literature. Arhan E; Serdaroğlu A; Hirfanoğlu T; Kurt G Childs Nerv Syst; 2018 Sep; 34(9):1799-1801. PubMed ID: 29680919 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Treatment with Transcutaneous Vagus Nerve Stimulation in 17 Patients with Refractory Epilepsy Evaluated by Electroencephalogram, Seizure Frequency, and Quality of Life. Liu A; Rong P; Gong L; Song L; Wang X; Li L; Wang Y Med Sci Monit; 2018 Nov; 24():8439-8448. PubMed ID: 30467307 [TBL] [Abstract][Full Text] [Related]
9. [Basic and advanced treatment of children and adults with epilepsy]. Hoei-Hansen CE; Tinggaard J; Kløvgaard M; Sabers A Ugeskr Laeger; 2022 Jun; 184(26):. PubMed ID: 35786227 [TBL] [Abstract][Full Text] [Related]
10. Seizure freedom as an outcome in epilepsy treatment clinical trials. Halford JJ; Edwards JC Acta Neurol Scand; 2020 Aug; 142(2):91-107. PubMed ID: 32353166 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of economic evaluations of treatments for patients with epilepsy. Wijnen BFM; van Mastrigt GAPG; Evers SMAA; Gershuni O; Lambrechts DAJE; Majoie MHJM; Postulart D; Aldenkamp BAP; de Kinderen RJA Epilepsia; 2017 May; 58(5):706-726. PubMed ID: 28098939 [TBL] [Abstract][Full Text] [Related]
12. Neuromodulation in Pediatric Epilepsy. Ali I; Houck K Neurol Clin; 2021 Aug; 39(3):797-810. PubMed ID: 34215387 [TBL] [Abstract][Full Text] [Related]
13. Seizure clusters: A common, understudied and undertreated phenomenon in refractory epilepsy. Komaragiri A; Detyniecki K; Hirsch LJ Epilepsy Behav; 2016 Jun; 59():83-6. PubMed ID: 27116535 [TBL] [Abstract][Full Text] [Related]
14. Drug-resistant epilepsy in Indian children at a tertiary-care public hospital. Kharod P; Mishra D; Juneja M Childs Nerv Syst; 2019 May; 35(5):775-778. PubMed ID: 30758667 [TBL] [Abstract][Full Text] [Related]
15. Pharmacoresistance - Epidemiology, mechanisms, and impact on epilepsy treatment. Janmohamed M; Brodie MJ; Kwan P Neuropharmacology; 2020 May; 168():107790. PubMed ID: 31560910 [TBL] [Abstract][Full Text] [Related]
16. Modified ketogenic diets in adults with refractory epilepsy: Efficacious improvements in seizure frequency, seizure severity, and quality of life. Roehl K; Falco-Walter J; Ouyang B; Balabanov A Epilepsy Behav; 2019 Apr; 93():113-118. PubMed ID: 30867113 [TBL] [Abstract][Full Text] [Related]
17. A side-by-side comparison of fine-tuning options for treatment of medically refractory epilepsy: Antiseizure medications, vagus nerve stimulation and ketogenic diet therapies. Bonno D; Vanatta L; Kossoff E Epilepsy Res; 2024 Oct; 206():107441. PubMed ID: 39216316 [TBL] [Abstract][Full Text] [Related]